• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

围绝经期激素治疗期间诊断出的未分化子宫内膜癌:一例病例报告及文献综述

Undifferentiated endometrial carcinoma diagnosed during perimenopausal hormone therapy: a case report and literature review.

作者信息

Wang Ying, Zheng Yu-Tong, Zhang Ling, Cao Xue-Quan, Lin Zhu, Liu Hong-Yu, Hu Qiong-Ying

机构信息

The Taizhou Central Hospital (Taizhou University Hospital), School of Medicine, Taizhou University, Taizhou, Zhejiang, China.

出版信息

Front Oncol. 2024 Nov 22;14:1440246. doi: 10.3389/fonc.2024.1440246. eCollection 2024.

DOI:10.3389/fonc.2024.1440246
PMID:39650060
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11620970/
Abstract

Uterine corpus endometrial carcinoma, one of the three most frequent cancers of the female reproductive system, primarily affects women who are perimenopausal or postmenopausal. Moreover, it is an epithelial cancer that develops in the endometrium, which is classified as either estrogen-dependent (type I) or non-estrogen-dependent (type II). Non-estrogen-dependent endometrial cancers include plasma cell carcinoma and undifferentiated/dedifferentiated endometrial carcinoma. Undifferentiated endometrial carcinoma is a rare but aggressive endometrial epithelial cancer that lacks any histologic differentiation and is classified as a high-grade endometrial cancer. This case presents that a patient had uterine corpus endometrial carcinoma during perimenopausal hormone therapy, and the patient was treated with sequential estrogen-progestin treatment for 3 years. During that period, she did not undergo a follow-up examination for the last 2 years due to the pandemic. Undifferentiated endometrial carcinoma is a special type of endometrial cancer that is not hormone-dependent, and whether the occurrence of this case is related to perimenopausal hormone therapy needs to be verified by more evidence-based clinical cases and further studies.

摘要

子宫体子宫内膜癌是女性生殖系统最常见的三种癌症之一,主要影响围绝经期或绝经后的女性。此外,它是一种发生于子宫内膜的上皮性癌症,可分为雌激素依赖型(I型)或非雌激素依赖型(II型)。非雌激素依赖型子宫内膜癌包括浆细胞癌和未分化/去分化子宫内膜癌。未分化子宫内膜癌是一种罕见但侵袭性强的子宫内膜上皮性癌症,缺乏任何组织学分化,被归类为高级别子宫内膜癌。本病例介绍了一名患者在围绝经期激素治疗期间患子宫体子宫内膜癌,该患者接受序贯雌激素 - 孕激素治疗3年。在此期间,由于疫情,她在最后2年未进行随访检查。未分化子宫内膜癌是一种特殊类型的非激素依赖型子宫内膜癌,该病例的发生是否与围绝经期激素治疗有关,需要更多基于证据的临床病例和进一步研究来证实。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff7f/11620970/815d2728864c/fonc-14-1440246-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff7f/11620970/821446205f58/fonc-14-1440246-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff7f/11620970/3f724872e347/fonc-14-1440246-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff7f/11620970/815d2728864c/fonc-14-1440246-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff7f/11620970/821446205f58/fonc-14-1440246-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff7f/11620970/3f724872e347/fonc-14-1440246-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff7f/11620970/815d2728864c/fonc-14-1440246-g003.jpg

相似文献

1
Undifferentiated endometrial carcinoma diagnosed during perimenopausal hormone therapy: a case report and literature review.围绝经期激素治疗期间诊断出的未分化子宫内膜癌:一例病例报告及文献综述
Front Oncol. 2024 Nov 22;14:1440246. doi: 10.3389/fonc.2024.1440246. eCollection 2024.
2
Role of epithelial-mesenchymal transition factors in the histogenesis of uterine carcinomas.上皮-间充质转化因子在子宫癌发生中的作用。
Virchows Arch. 2019 Jul;475(1):85-94. doi: 10.1007/s00428-019-02532-w. Epub 2019 Feb 9.
3
Endometrial Thickness as a Predictor of Endometrial Malignancy among the Women Presenting with Abnormal Uterine Bleeding.子宫内膜厚度作为异常子宫出血患者子宫内膜恶性肿瘤的预测指标。
Mymensingh Med J. 2024 Jul;33(3):677-684.
4
Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.绝经后女性队列中,绝经后使用雌激素加孕激素和单纯使用雌激素者的子宫内膜癌风险。
Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1724-31. doi: 10.1158/1055-9965.EPI-05-0111.
5
Dedifferentiated endometrial carcinoma: A report of three cases and review of the literature.去分化子宫内膜癌:三例报告及文献复习
Mol Clin Oncol. 2017 Dec;7(6):1008-1012. doi: 10.3892/mco.2017.1437. Epub 2017 Oct 3.
6
GnRH-a-Induced Perimenopausal Rat Modeling and Black Cohosh Preparations' Effect on Rat's Reproductive Endocrine.GnRH-a 诱导的围绝经期大鼠模型及黑升麻制剂对大鼠生殖内分泌的影响。
Front Endocrinol (Lausanne). 2021 Dec 24;12:683552. doi: 10.3389/fendo.2021.683552. eCollection 2021.
7
Ultrasonic and Histopathological Evaluation to Exclude Premalignant and Malignant Lesions in Perimenopausal and Postmenopausal Women Presenting as Abnormal Uterine Bleeding.超声及组织病理学评估以排除出现异常子宫出血的围绝经期及绝经后女性的癌前病变和恶性病变
J Obstet Gynaecol India. 2019 Oct;69(Suppl 2):171-176. doi: 10.1007/s13224-018-1166-9. Epub 2018 Aug 21.
8
Analysis of Characteristics of Endometrial Carcinoma in Peri- and Postmenopausal Women with Abnormal Uterine Bleeding.异常子宫出血的围绝经期和绝经后女性子宫内膜癌特征分析
Biomed Res Int. 2024 Feb 24;2024:6509171. doi: 10.1155/2024/6509171. eCollection 2024.
9
Ultrasonographic evaluation of the endometrium in postmenopausal vaginal bleeding.绝经后阴道出血患者子宫内膜的超声评估
Radiol Clin North Am. 2003 Jul;41(4):769-80. doi: 10.1016/s0033-8389(03)00060-5.
10
A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.一项关于释放雌二醇的阴道环联合口服孕激素与经皮雌激素联合释放左炔诺孕酮宫内节育器效果的对比研究:临床发现及子宫内膜反应
Int J Fertil Menopausal Stud. 1996 Nov-Dec;41(6):522-7.

引用本文的文献

1
The Role of Non-Coding RNAs in the Regulation of Oncogenic Pathways in Breast and Gynaecological Cancers.非编码RNA在乳腺癌和妇科癌症致癌途径调控中的作用
Noncoding RNA. 2025 Aug 6;11(4):61. doi: 10.3390/ncrna11040061.
2
Immunogenic cell death-related genes as prognostic biomarkers and therapeutic insights in uterine corpus endometrial carcinoma: an integrative bioinformatics analysis.免疫原性细胞死亡相关基因作为子宫体子宫内膜癌的预后生物标志物及治疗见解:一项综合生物信息学分析
Front Oncol. 2025 Jul 24;15:1588703. doi: 10.3389/fonc.2025.1588703. eCollection 2025.
3
The immune microenvironment in endometrial carcinoma: mechanisms and therapeutic targeting.

本文引用的文献

1
Dedifferentiated Endometrial Carcinoma: A Rare Aggressive Neoplasm-Clinical, Morphological and Immunohistochemical Features.去分化子宫内膜癌:一种罕见的侵袭性肿瘤——临床、形态学及免疫组化特征
Cancers (Basel). 2023 Oct 26;15(21):5155. doi: 10.3390/cancers15215155.
2
Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma.SMARCA4 缺陷型未分化子宫肉瘤的病理特征和免疫微环境。
Diagn Pathol. 2023 May 16;18(1):62. doi: 10.1186/s13000-023-01347-3.
3
Dedifferentiated endometrial carcinoma arising from serous carcinoma: Diagnostic challenges and recommendations.
子宫内膜癌中的免疫微环境:机制与治疗靶点
Front Immunol. 2025 Jul 17;16:1586315. doi: 10.3389/fimmu.2025.1586315. eCollection 2025.
浆液性癌来源的去分化子宫内膜癌:诊断挑战与建议
Gynecol Oncol Rep. 2023 Apr 13;47:101188. doi: 10.1016/j.gore.2023.101188. eCollection 2023 Jun.
4
Identification of novel key genes associated with uterine corpus endometrial carcinoma progression and prognosis.鉴定与子宫内膜癌进展和预后相关的新型关键基因。
Ann Transl Med. 2023 Jan 31;11(2):100. doi: 10.21037/atm-22-6461.
5
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.子宫肿瘤,第1.2023版,美国国立综合癌症网络(NCCN)肿瘤学临床实践指南
J Natl Compr Canc Netw. 2023 Feb;21(2):181-209. doi: 10.6004/jnccn.2023.0006.
6
Endometrial cancer: Part I. Basic concept.子宫内膜癌:第一部分。基本概念。
Taiwan J Obstet Gynecol. 2022 Nov;61(6):951-959. doi: 10.1016/j.tjog.2022.09.001.
7
Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review.子宫内膜样型子宫内膜癌 2 级 IA 期(FIGO)患者的保留生育力方法:定性系统评价。
Biomed Res Int. 2022 Sep 27;2022:4070368. doi: 10.1155/2022/4070368. eCollection 2022.
8
Cancer treatment and survivorship statistics, 2022.2022 年癌症治疗和生存统计。
CA Cancer J Clin. 2022 Sep;72(5):409-436. doi: 10.3322/caac.21731. Epub 2022 Jun 23.
9
A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets in Uterine Corpus Endometrial cancer.黏附 G 蛋白偶联受体相关性研究及其作为子宫体子宫内膜癌潜在治疗靶点的价值。
Int Immunopharmacol. 2022 Jul;108:108743. doi: 10.1016/j.intimp.2022.108743. Epub 2022 Apr 9.
10
Rare Subtype of Endometrial Cancer: Undifferentiated/Dedifferentiated Endometrial Carcinoma, from Genetic Aspects to Clinical Practice.罕见的子宫内膜癌亚型:未分化/去分化子宫内膜癌,从遗传角度到临床实践。
Int J Mol Sci. 2022 Mar 30;23(7):3794. doi: 10.3390/ijms23073794.